{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:46:27Z","timestamp":1768070787340,"version":"3.49.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Robertson Therapeutic Development Fund"},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1093\/ijnp\/pyy034","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T19:10:00Z","timestamp":1522437000000},"page":"847-857","source":"Crossref","is-referenced-by-count":35,"title":["Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice"],"prefix":"10.1093","volume":"21","author":[{"given":"Amelia D","family":"Dunn","sequence":"first","affiliation":[{"name":"Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Reed","sequence":"additional","affiliation":[{"name":"Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Guariglia","sequence":"additional","affiliation":[{"name":"Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra M","family":"Dunn","sequence":"additional","affiliation":[{"name":"Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M","family":"Hillman","sequence":"additional","affiliation":[{"name":"Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[{"name":"Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"key\n\t\t\t\t20180901065404_CIT0001","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/syn.20436","article-title":"Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose \u201cBinge\u201d cocaine administration paradigm","volume":"61","author":"Bailey","year":"2007","journal-title":"Synapse"},{"key":"key\n\t\t\t\t20180901065404_CIT0002","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180901065404_CIT0003","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, jdtic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20180901065404_CIT0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20180901065404_CIT0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-2914-6_12","article-title":"Approaches to assess functional selectivity in gpcrs: evaluating G protein signaling in an endogenous environment","volume":"1335","author":"Bohn","year":"2015","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20180901065404_CIT0006","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1016\/j.bmc.2014.04.054","article-title":"Combination of cyclohexane and piperazine based \u03ba-opioid receptor agonists: synthesis and pharmacological evaluation of trans, trans-configured perhydroquinoxalines","volume":"22","author":"Bourgeois","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0007","doi-asserted-by":"crossref","first-page":"ra117","DOI":"10.1126\/scisignal.aai8441","article-title":"Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria","volume":"9","author":"Brust","year":"2016","journal-title":"Sci Signal"},{"key":"key\n\t\t\t\t20180901065404_CIT0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-2999(99)00640-8","article-title":"Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys","volume":"383","author":"Butelman","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0009","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.108.145342","article-title":"Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid","volume":"328","author":"Butelman","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180901065404_CIT0010","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0011","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","article-title":"Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum","volume":"4","author":"Daunais","year":"1993","journal-title":"Neuroreport"},{"key":"key\n\t\t\t\t20180901065404_CIT0012","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00210-008-0260-4","article-title":"On the analysis of ligand-directed signaling at G protein-coupled receptors","volume":"377","author":"Ehlert","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0013","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1021\/acs.jmedchem.7b00981","article-title":"Highly potent and selective new diphenethylamines interacting with the \u03ba-opioid receptor: synthesis, pharmacology, and structure-activity relationships","volume":"60","author":"Erli","year":"2017","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0014","doi-asserted-by":"crossref","first-page":"313","DOI":"10.33549\/physiolres.932386","article-title":"Daily subacute paraquat exposure decreases muscle function and substantia nigra dopamine level","volume":"62","author":"Fahim","year":"2013","journal-title":"Physiol Res"},{"key":"key\n\t\t\t\t20180901065404_CIT0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0028-3908(91)90068-M","article-title":"The dopamine D2 agonists RU 24213 and RU 24926 are also KAPPA-opioid receptor antagonists","volume":"30","author":"Fortin","year":"1991","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20180901065404_CIT0016","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/cn200128x","article-title":"Discovery of small molecule kappa opioid receptor agonist and antagonist chemotypes through a HTS and hit refinement strategy","volume":"3","author":"Frankowski","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"key\n\t\t\t\t20180901065404_CIT0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/ml100040t","article-title":"N-alkyl-octahydroisoquinolin-1-one-8-carboxamides: a novel class of selective, nonbasic, nitrogen-containing \u03ba-opioid receptor ligands","volume":"1","author":"Frankowski","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"key\n\t\t\t\t20180901065404_CIT0018","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm00047a006","article-title":"Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl group","volume":"37","author":"Giardina","year":"1994","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0019","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/ml5000542","article-title":"Synthesis and pharmacology of a novel \u03ba opioid receptor (KOR) agonist with a 1,3,5-trioxazatriquinane skeleton","volume":"5","author":"Hirayama","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"key\n\t\t\t\t20180901065404_CIT0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5055\/jom.2016.0321","article-title":"The emerging therapeutic roles of \u03ba-opioid agonists","volume":"12","author":"Jones","year":"2016","journal-title":"J Opioid Manag"},{"key":"key\n\t\t\t\t20180901065404_CIT0021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"key\n\t\t\t\t20180901065404_CIT0022","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(24)37950-9","article-title":"Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions","volume":"288","author":"Kreek","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180901065404_CIT0023","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/acschemneuro.5b00092","article-title":"Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK \u00bd phosphorylation while preserving G protein over \u03b2arrestin2 signaling bias","volume":"6","author":"Lovell","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"key\n\t\t\t\t20180901065404_CIT0024","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects","volume":"54","author":"Lowe","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0025a","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-3565(25)23043-9","article-title":"Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain","volume":"256","author":"Manzanares","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180901065404_CIT0025","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1471-4159.2008.05745.x","article-title":"Kappa opioids promote the proliferation of astrocytes via gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways","volume":"107","author":"McLennan","year":"2008","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20180901065404_CIT0026","doi-asserted-by":"crossref","first-page":"H856","DOI":"10.1152\/ajpheart.00327.2013","article-title":"The \u03b2-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium","volume":"305","author":"Monasky","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180901065404_CIT0027","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bmcl.2009.11.027","article-title":"Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology","volume":"20","author":"Nagase","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20180901065404_CIT0028","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science"},{"key":"key\n\t\t\t\t20180901065404_CIT0028a","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/npp.2017.245","article-title":"Repeated administration of Opra Kappa (LY2456302), a novel, short- acting, selective KOP-r antagonist, in persons with and without cocaine dependence","volume":"43","author":"Reed","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20180901065404_CIT0029","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1021\/jm501521d","article-title":"Synthesis and \u03ba-opioid receptor activity of furan-substituted salvinorin A analogues","volume":"57","author":"Riley","year":"2014","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00192549","article-title":"The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist","volume":"46","author":"Rimoy","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20180901065404_CIT0032","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1021\/acs.joc.6b01350","article-title":"Synthesis of kappa opioid antagonists based on pyrrolo[1,2-\u03b1]quinoxalinones using an N-arylation\/condensation\/oxidation reaction sequence","volume":"81","author":"Scarry","year":"2016","journal-title":"J Org Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0033","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130051016","article-title":"U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking","volume":"144","author":"Schenk","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20180901065404_CIT0034","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180901065404_CIT0035","doi-asserted-by":"crossref","first-page":"22387","DOI":"10.1074\/jbc.M113.476234","article-title":"Functional selectivity of 6\u2019-guanidinonaltrindole (6\u2019-GNTI) at \u03ba-opioid receptors in striatal neurons","volume":"288","author":"Schmid","year":"2013","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0036","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects vs morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain"},{"key":"key\n\t\t\t\t20180901065404_CIT0037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0169-328X(95)00319-N","article-title":"Regulation of kappa opioid receptor mRNA in the rat brain by \u201cBinge\u2019 pattern cocaine administration and correlation with preprodynorphin mRNA","volume":"38","author":"Spangler","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"key\n\t\t\t\t20180901065404_CIT0038","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","article-title":"\u2018Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen","volume":"19","author":"Spangler","year":"1993","journal-title":"Brain Res Mol Brain Res"},{"key":"key\n\t\t\t\t20180901065404_CIT0039","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1021\/jm301258w","article-title":"Discovery and pharmacological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective \u03ba opioid receptor agonist","volume":"55","author":"Spetea","year":"2012","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180901065404_CIT0040","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/bph.13854","article-title":"Selective \u03ba receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice","volume":"174","author":"Spetea","year":"2017","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0041","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/mol.114.096503","article-title":"A novel method for analyzing extremely biased agonism at G protein-coupled receptors","volume":"87","author":"Stahl","year":"2015","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0042","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(92)90912-S","article-title":"Chronic cocaine alters brain mu opioid receptors","volume":"584","author":"Unterwald","year":"1992","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20180901065404_CIT0043","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","article-title":"Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors","volume":"5","author":"Unterwald","year":"1994","journal-title":"Neuroreport"},{"key":"key\n\t\t\t\t20180901065404_CIT0044","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00213-017-4647-0","article-title":"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats","volume":"234","author":"Valenza","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20180901065404_CIT0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van\u2019t Veer","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20180901065404_CIT0046","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t20180901065404_CIT0047","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist","volume":"9","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev"},{"key":"key\n\t\t\t\t20180901065404_CIT0048","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/jpet.114.216820","article-title":"The G protein \u2013 biased k -opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo","volume":"352","author":"White","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180901065404_CIT0049","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/mol.113.089649","article-title":"Identification of novel functionally selective \u03ba-opioid receptor scaffolds","volume":"85","author":"White","year":"2013","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20180901065404_CIT0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","article-title":"Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"172","author":"Zhang","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20180901065404_CIT0051","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20180901065404_CIT0052","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm1196-1225","article-title":"Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving","volume":"2","author":"Zubieta","year":"1996","journal-title":"Nat Med"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/21\/9\/847\/25645736\/pyy034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:10:39Z","timestamp":1751526639000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/21\/9\/847\/4960012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,4,4]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyy034","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,4,4]]}}}